Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.58 USD | +2.10% | +18.16% | -10.95% |
04-26 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
03-22 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Sales 2024 * | 10M 796M | Sales 2025 * | 6.25M 498M | Capitalization | 1.16B 92.24B |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.75B | Net income 2025 * | -25M -1.99B | EV / Sales 2024 * | 110 x |
Net cash position 2024 * | 63.14M 5.03B | Net cash position 2025 * | 40.52M 3.23B | EV / Sales 2025 * | 179 x |
P/E ratio 2024 * |
-51.9
x | P/E ratio 2025 * |
-48.3
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.31% |
Latest transcript on Belite Bio, Inc
1 day | +2.49% | ||
1 week | +18.16% | ||
Current month | +6.18% | ||
1 month | +10.38% | ||
3 months | -10.52% | ||
6 months | +6.68% | ||
Current year | -10.95% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 26/03/18 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 31/10/20 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/10/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 31/03/22 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 31/03/22 |
John Longo
BRD | Director/Board Member | 55 | 31/03/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 40.58 | +2.10% | 29 560 |
26/04/24 | 39.75 | +4.61% | 46,599 |
25/04/24 | 38 | +1.96% | 16,035 |
24/04/24 | 37.27 | +0.73% | 32,733 |
23/04/24 | 37 | +7.31% | 38,820 |
Delayed Quote Nasdaq, April 29, 2024 at 08:55 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.95% | 1.16B | |
+1.85% | 42.75B | |
+47.70% | 41.61B | |
+12.43% | 41.34B | |
-8.83% | 26.59B | |
+7.52% | 25.49B | |
-23.07% | 18.12B | |
+30.55% | 12.24B | |
-2.16% | 11.76B | |
+8.19% | 11B |
- Stock Market
- Equities
- BLTE Stock